Serum Amyloid P Component Binding to Shiga Toxin 2 Requires Both A Subunit and B Pentamer

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Infection and Immunity

• Publication date

  2003-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.71.10.6075-6078.2003PMID 14500533PMCID PMC201105
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands.

  2003cited by this paper
• Cloned Shiga Toxin 2 B Subunit Induces Apoptosis in Ramos Burkitt's Lymphoma B Cells

  2003cited by this paper
• Role of Shiga toxin 2 (Stx2)-binding protein, human serum amyloid P component (HuSAP), in Shiga toxin-producing Escherichia coli infections: assumption from in vitro and in vivo study using HuSAP and anti-Stx2 humanized monoclonal antibody TMA-15.

  2003cited by this paper
• Cloned Shiga Toxin 2 B Subunit Induces Apoptosis in Ramos Burkitt's Lymphoma B Cells

  2002cited by this paper
• Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model.

  2002cited by this paper
• Serum Amyloid P Component Is the Shiga Toxin 2-neutralizing Factor in Human Blood*

  2001influential reference
• Immunoprophylactic potential of cloned Shiga toxin 2 B subunit.

  2001cited by this paper
• Shiga Toxins Induce, Superinduce, and Stabilize a Variety of C-X-C Chemokine mRNAs in Intestinal Epithelial Cells, Resulting in Increased Chemokine Expression

  2001cited by this paper
• Bcl-2 antiapoptotic protein mediates verotoxin II-induced cell death: possible association between bcl-2 and tissue failure by E. coli O157:H7.

  2000cited by this paper
• Epidemic of Gastrointestinal Tract Infection Including Hemorrhagic Colitis Attributable to Shiga Toxin 1-producingEscherichia coli O118:H2 at a Junior High School in Japan

  1999cited by this paper
• Induction of cytokines in a human colon epithelial cell line by Shiga toxin 1 (Stx1) and Stx2 but not by non‐toxic mutant Stx1 which lacks N‐glycosidase activity

  1999cited by this paper
• Affinity purification of Shiga-like toxin I and Shiga-like toxin II

  1998cited by this paper
• Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells.

  1995cited by this paper
• Investigation of Shiga-like toxin binding to chemically synthesized oligosaccharide sequences.

  1991cited by this paper
• Serum amyloid P component in chronic renal failure and dialysis.

  1991cited by this paper
• Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function.

  1991cited by this paper
• Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects.

  1990cited by this paper
• Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects.

  1990cited by this paper
• Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections.

  1989cited by this paper

• An antibiotic derivative as a new potential tool in the prevention of hemolytic uremic syndrome

  2025cites this paper
• One problem, multiple potential targets: Where are we now in the development of Shiga toxin inhibitors?

  2024cites this paper
• Detection of Cleaved Stx2a in the Blood of STEC-Infected Patients

  2023cites this paper
• Therapeutic Uses of Bacterial Subunit Toxins

  2021cites this paper
• Extracellular Vesicles and Renal Endothelial Cells: a Fatal Attraction in Hemolytic Uremic Syndrome.

  2021cites this paper
• Molecular Biology of Escherichia coli Shiga Toxins’ Effects on Mammalian Cells

  2020cites this paper
• The structure of the Shiga toxin 2a A‐subunit dictates the interactions of the toxin with blood components

  2019cites this paper
• The Pentraxins 1975–2018: Serendipity, Diagnostics and Drugs

  2018cites this paper
• Structural Basis for the Specific Neutralization of Stx2a with a Camelid Single Domain Antibody Fragment

  2018cites this paper
• Interaction of the EHEC virulence factor Shiga toxin 2a with the innate immune system and the role of complement in EHEC-associated hemolytic uremic syndrome / by Sneha Chatterjee

  2018cites this paper
• Soluble Toll-Like Receptor 4 Impairs the Interaction of Shiga Toxin 2a with Human Serum Amyloid P Component

  2018cites this paper
• Detection Methods for Shiga Toxins and Shiga Toxin-Producing E. coli

  2017cites this paper
• Structure of Shiga Toxins and Other AB 5 Toxins

  2017cites this paper
• Postinfectious Hemolytic Uremic Syndrome

  2016cites this paper
• A Rapid and Sensitive Method to Measure the Functional Activity of Shiga Toxins in Human Serum

  2015cites this paper
• Mass Spectrometry-Based Method of Detecting and Distinguishing Type 1 and Type 2 Shiga-Like Toxins in Human Serum

  2015cites this paper
• Glycolipid Binding Preferences of Shiga Toxin Variants

  2014cites this paper
• New Therapeutic Developments against Shiga Toxin-Producing Escherichia coli

  2014cites this paper
• Comparisons of Native Shiga Toxins (Stxs) Type 1 and 2 with Chimeric Toxins Indicate that the Source of the Binding Subunit Dictates Degree of Toxicity

  2014cites this paper
• Comparisons of Native and Chimeric Shiga Toxins Indicate that the Binding Subunit Dictates Degree of Toxicity

  2014cites this paper
• Binding of Pk-Trisaccharide Analogs of Globotriaosylceramide to Shiga Toxin Variants

  2013cites this paper
• Thermodynamic, Structural, And Functional Characterization Of MINT: A Notch Signaling Corepressor

  2013cites this paper
• The Interactions of Human Neutrophils with Shiga Toxins and Related Plant Toxins: Danger or Safety?

  2012influential citation
• Virulence traits of Shiga toxin producing Escherichia coli

  2011cites this paper
• Lipopolysaccharide Renders Transgenic Mice Expressing Human Serum Amyloid P Component Sensitive to Shiga Toxin 2

  2011cites this paper
• Determination of the Molecular Basis for the Difference in Potency between Shiga Toxins 1 and 2

  2010influential citation
• Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration

  2010cites this paper
• Molecular Basis of Differential B-Pentamer Stability of Shiga Toxins 1 and 2

  2010influential citation
• Interactions between Shiga toxins and human polymorphonuclear leukocytes

  2008cites this paper
• Binding of fluorescent or native Stx 1 to PMN in blood

  2008cites this paper
• In vivo supramolecular templating enhances the activity of multivalent ligands: A potential therapeutic against the Escherichia coli O157 AB5 toxins

  2008cites this paper
• Differential binding of Shiga toxin 2 to human and murine neutrophils.

  2007cites this paper
• Pathogenic Mechanisms of the Enterohemorrhagic Escherichia coli—Some New Insights

  2007cites this paper
• Human serum amyloid P component protects against Escherichia coli O157:H7 Shiga toxin 2 in vivo: therapeutic implications for hemolytic-uremic syndrome.

  2006cites this paper
• Shiga toxin-encoding phage from Escherichia coli O157:H7 : interactions with non-pathogenic E. coli and implications for toxin production.

  2004cites this paper